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Abstract
To date, non-pharmacological interventions (NPI) have been the mainstay for controlling the coronavirus disease-2019 
(COVID-19) pandemic. While NPIs are effective in preventing health systems overload, these long-term measures are 
likely to have significant adverse economic consequences. Therefore, many countries are currently considering to lift the 
NPIs—increasing the likelihood of disease resurgence. In this regard, dynamic NPIs, with intervals of relaxed social distanc-
ing, may provide a more suitable alternative. However, the ideal frequency and duration of intermittent NPIs, and the ideal 
“break” when interventions can be temporarily relaxed, remain uncertain, especially in resource-poor settings. We employed 
a multivariate prediction model, based on up-to-date transmission and clinical parameters, to simulate outbreak trajectories 
in 16 countries, from diverse regions and economic categories. In each country, we then modelled the impacts on intensive 
care unit (ICU) admissions and deaths over an 18-month period for following scenarios: (1) no intervention, (2) consecutive 
cycles of mitigation measures followed by a relaxation period, and (3) consecutive cycles of suppression measures followed 
by a relaxation period. We defined these dynamic interventions based on reduction of the mean reproduction number during 
each cycle, assuming a basic reproduction number (R0) of 2.2 for no intervention, and subsequent effective reproduction 
numbers (R) of 0.8 and 0.5 for illustrative dynamic mitigation and suppression interventions, respectively. We found that 
dynamic cycles of 50-day mitigation followed by a 30-day relaxation reduced transmission, however, were unsuccessful in 
lowering ICU hospitalizations below manageable limits. By contrast, dynamic cycles of 50-day suppression followed by a 
30-day relaxation kept the ICU demands below the national capacities. Additionally, we estimated that a significant number 
of new infections and deaths, especially in resource-poor countries, would be averted if these dynamic suppression measures 
were kept in place over an 18-month period. This multi-country analysis demonstrates that intermittent reductions of R below 
1 through a potential combination of suppression interventions and relaxation can be an effective strategy for COVID-19 
pandemic control. Such a “schedule” of social distancing might be particularly relevant to low-income countries, where a 
single, prolonged suppression intervention is unsustainable. Efficient implementation of dynamic suppression interventions, 
therefore, confers a pragmatic option to: (1) prevent critical care overload and deaths, (2) gain time to develop preventive 
and clinical measures, and (3) reduce economic hardship globally.
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Introduction
Coronavirus disease 2019 (COVID-19) pandemic has 
imposed an unprecedented challenge to global healthcare 
systems, societies, and governments [1]. As of May 16, 
2020, the severe acute respiratory syndrome coronavirus-2 
(SARS-CoV-2, causative pathogen for COVID-19) has 
been detected in every country, with more than 4.6 million 
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confirmed cases and a death toll exceeding 300,000 world-
wide [2]. Furthermore, recent pandemic model projections 
estimate that COVID-19 could result in ~ 40 million deaths 
globally this year, if no interventions are implemented 
[3]. To date, in the absence of efficacious pharmaceuti-
cal measures for prevention or treatment, the principal 
strategy to control COVID-19 has focused on community-
based, non-pharmaceutical interventions (NPIs) [4]. These 
NPIs typically include a package of mitigation and sup-
pression measures (e.g., case-based isolation, shielding 
of vulnerable groups, school closures, restricting public 
events and lockdowns), that aim to minimize person-to-
person transmissions of SARS-CoV-2 through social dis-
tancing [5].
While NPIs are effective (e.g., in blunting the peak 
of the epidemic, preventing health systems overload and 
reducing incidence) [4, 6, 7], these long-term measures 
are also associated with significant unemployment, eco-
nomic hardship and social disruption (with surveys from 
resource-poor settings showing an average fall in income 
by 70% and consumption expenditure by 30%) [8]. There 
is a growing concern whether these prolonged interven-
tions are sustainable given the widespread disparities in 
economic resilience and health sector capacities glob-
ally [9]. As a result, many countries worldwide are cur-
rently considering to lift the lockdowns—increasing the 
likelihood of disease resurgence. In this regard, dynamic 
NPIs with intervals of relaxed social distancing, may serve 
as a realistic alternative to achieve the NPI goals, with 
minimal adverse socioeconomic consequences. However, 
it remains unclear (1) what should be the frequency and 
duration of such dynamic NPIs, (2) what should be the 
ideal “break” when interventions can be relaxed temporar-
ily before case numbers resurge, and (3) which dynamic 
NPI strategy should be adapted globally across regions 
with diverse health and economic infrastructures. Address-
ing these issues is essential to devise feasible, context-
specific policies to prevent collapse of healthcare sys-
tems, reduce premature deaths and minimize detrimental 
impacts on national economies associated with prolonged 
continuous NPIs.
To address these uncertainties, we have employed a 
transmission dynamic model comparing sixteen countries 
that vary in setting and income groupings. Our key aims 
were to: (1) calculate age-standardized estimates of case-
severity and fatality in included countries; (2) estimate 
the impact of an uncontrolled course of the pandemic in 
each country, given the current resources of their health 
systems (counterfactual), (3) compare continuous versus 
intermittent combinations of mitigation/suppression and 
relaxation strategies, over an 18-month period (i.e., opti-
mistic timeline for an efficacious vaccine to be developed 
[10]); and (4) identify strategies that help keep the number 
of projected cases requiring critical care within a manage-
able limit, while also considering a feasible duration of 
these interventions.
Methods
This study was conducted according to the to the TRIPOD 
reporting guideline [11] for prediction modelling studies 
(Supplementary Appendix 1).
Study design, source of data and study settings
We have employed a multivariate prediction model to 
describe COVID-19 transmission dynamics under various 
NPIs. Since the distributions of age and underlying co-
morbidities may differ importantly by country, region and 
economic status [4] we have hypothesised that the predicted 
mortality impacts for NPI strategies will differ importantly. 
Therefore, for this current study, we have considered sev-
eral circumstances. First, we used age-standardized clinical 
dynamic estimates to model the epidemic trajectories in 16 
different countries (which comprise roughly a quarter of the 
global population), by accessing available country-specific 
age structure data. Second, we selected these countries from 
diverse geographical regions: Western Europe (The Nether-
lands, Belgium), South America (Chile, Colombia), North 
America (Mexico), Africa (South Africa, Nigeria, Ethiopia, 
Tanzania, Uganda), South Asia (India, Bangladesh, Pakistan 
Sri Lanka), West Asia (Yemen), and the Pacific (Australia). 
Third, these countries also represent all income categories 
equally, as defined by the World Bank [12]: four countries 
in every high (HIC), higher-middle (HMIC), lower-middle 
(LMIC) and low income (LIC) groups, respectively.
Intervention scenarios, predictors and outcomes
We considered case isolation at home, voluntary home 
quarantine, closure of schools and universities, and social 
distancing of the entire population as physical distancing 
measures. We defined the study interventions scenarios 
based on reduction of the reproduction number during the 
duration of intervention (R). For this, we assumed a basic 
reproduction number [13] (R0, the average number of sec-
ondary infections arising from a typical single infection in a 
completely susceptible population) of 2.2 for uncontrolled 
spread of COVID-19, and effective reproduction numbers 
(R, average number of secondary cases per infectious case 
in presence of control measures and a partially immune 
population) of 0.8 and 0.5 for mitigation and suppression 
interventions, respectively. These assumptions were based 
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on recent work by Jarvis et al. [14] who reported a 73% 
reduction in the average daily number of contacts observed 
per participant for physical distancing measures. This cor-
responded to a pre-intervention R0 value of 2.6 to reduce to 
a post-intervention R value of 0.62 (95% confidence inter-
val: 0.37–0.89) following strict suppression measures. Even 
though the exact relationship between changes in the number 
of social contacts and R0 remains unclear, we used these 
findings as the rationale to calculate our study’s effective R 
values of 0.5 and 0.8 for the interventions. These numbers 
are in agreement with recent estimates for several European 
countries and arguably reflect the expected effects of a some-
what relaxed and more stringent lockdown [15].
Based on this approach, or each country, the following 
intervention scenarios were considered: (1) no intervention 
(i.e., counterfactual scenario), (2) consecutive cycles of miti-
gation (a combination of measures, such as general social 
distancing measures, hygiene rules, case-based isolation, 
shielding of vulnerable groups, school closures or restricting 
of large public events; target R = 0.8), followed by a relaxa-
tion period (comprising of case-based home isolation of 
positive cases and shielding of vulnerable groups), (3) con-
secutive cycles of suppression (additional measures of strict 
physical distancing, including lockdowns; target R = 0.5) fol-
lowed by a relaxation period (as defined above), and (4) a 
continuous suppression measure with no relaxation.
In the absence of intervention, the assumed parameters 
for transmission dynamics yielded a characteristic rise-and-
fall timescale of infections of about 50 days, which we set 
to be the illustrative duration of intervention. Choosing a 
slightly longer period (e.g. 60 days) yielded similar out-
comes. The duration of breaks between interventions needs 
to be less than the intervention period for the interventions 
to be effective; therefore, we set the break duration to be 30 
days. When to intervene was determined by the initial frac-
tion of the population that was infected. For example, if the 
fraction was on the order of 1 part in 10,000 (or more), we 
set the initiation point for the intervention at Day 20. How-
ever, if the fraction was on the order of 1 part in 100,000 to 
1 million, we set the initiation point as Day 30. Similarly, if 
the fraction was on the order of 1 part in 10 million, we set 
this at Day 50. Changes in the initial fraction simply shift the 
curves back and forth in time without altering their shapes.
For each country, the outcomes of interest were (1) the 
number requiring intensive care unit (ICU) beds (primary 
outcome); and (2) total number of hospitalizations and 
deaths (secondary outcome), by different scenarios of NPIs, 
and within a time horizon of 18 months. We prioritized ICU 
care needs as the main outcome since this healthcare com-
ponent is in short supply in many resource-limited settings, 
and therefore, is a major determinant for adverse COVID-19 
outcomes.
Statistical methods for model calibration 
and age‑standardization
The analyses were based on a standard susceptible-
exposed-infected-recovered (SEIR) compartmental model 
[16] to describe the transmission of SARS-CoV-2 in 16 
countries under various NPI scenarios. The model consid-
ered additional compartments for hospitalization and ICU 
demand. Susceptible individuals S are infected by infec-
tious individuals I at a rate β. After an incubation period of 
1/σ = 5·2 days [17], exposed individuals E becomes infec-
tious I, and either clear the infection at a rate γ or progress 
to severe infection P with probability fP. The infectious 
period is taken to be 1/γ = 2·3 days, corresponding to a 
serial interval and generation time of 1/σ + 1/γ = 7·5 days 
[17]. The quantity fP is the proportion of infections that 
require hospitalization, for which we obtained age-specific 
estimates from a recent analysis of COVID-19 cases in 
China [18].
We applied these age-specific estimates to each indi-
vidual country’s population to get country-specific age-
standardized proportion of infections that require hospitali-
zation. We considered the delay between severe infection 
and hospitalization is 1/ω = 2·7 days [4]. Severely infected 
individuals P enter the hospital as H, after which they either 
leave the hospital at a rate κ or enter the ICU with prob-
ability fU. Age-stratified proportions of hospitalized cases 
requiring ICU care (fU) were based on the Imperial College 
COVID-19 Response Team’s Report [4], and then standard-
ized according to each country’s population age structure. 
The quantity 1/κ is the duration of non-ICU hospital stays, 
which we considered 8 days [4]. Patients U stay in ICU 
for 1/δ = 8 days [4], after which a fraction of them die (fD). 
The age-specific infectious fatality rate (IFR) were obtained 
from Verity et al. [18]. Those were subsequently applied 
to individual country’s population to get country-specific 
age-standardized IFRs (Supplementary Tables S1–S16). 
IFR is the product of fP, fU, and fD. The basic reproduc-
tion number is R0 = βN/γ = 2·2 [17, 19, 20], with N being 
the total population size of the country. The set of coupled 
ordinary differential equations that underpin our model are 
Box 1  Equations used in SEIR compartmental model
dS
dt
= −훽IS,
dE
dt
= 훽IS − 휎E,
dI
dt
= 휎E − 훾I,
dP
dt
= fP훾I − 휔P,
dH
dt
= 휔P − 휅H,
dU
dt
= fU휅H − 훿U,
dR
dt
=
(
1 − fP
)
훾I +
(
1 − fU
)
휅H + (1 − fD)훿U,
dD
dt
= fD훿U.
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presented in the Box 1. These equations in the SEIR model 
were solved numerically using the solve_ivp package in the 
Python programming language suite [21]; plots were cre-
ated using the matplotlib graphics package [22].
Results
Country‑specific characteristics and clinical 
dynamics
Demographic and health system-related characteristics 
Table  1 presents a summary of the demographic and 
health system-related characteristics for the included 
countries, grouped by their respective income levels. 
Briefly, the countries varied in population size (ranging 
from 11,539,326 in Belgium to 1,366,417,755 in India). 
The first cases were identified in a much later date in the 
LICs (~ late February–early March, 2020) compared to 
HIC countries such as Australia, the Netherlands and 
Belgium. Additionally, there were significant differences 
across countries with respect to healthcare infrastructure. 
For example, in the majority of LICs and LMICs, avail-
able hospital and ICU beds were < 1 bed per 1000 popu-
lation and < 1 bed per 100,000 population, respectively 
(Table 1).
Age-standardized estimates of case-severity and fatality 
Table 2 summarizes various COVID-19 relevant clinical 
dynamics estimated for each of the 16 included countries. 
Briefly, proportion of infected individuals who require 
hospitalization ranged from 1.61% in Uganda to 6.12% 
in the Netherlands, with higher proportions observed in 
HIC and UMICs compared to the other country categories. 
This pattern was similar for the proportion of hospitalized 
Table 1  Key demographic and health system-related characteristics of the 16 included countries
ICU intensive care unit
a Taken from various country-specific reports
b Taken from The World Bank Data on hospital bed [23]
c Taken from various country-specific reports
Size of popula-
tion
Number of 
initial infections 
(as of 1 April 
2020)a
Date of first 
case
Hospital beds 
per 1000 
 populationb
Total hospital 
beds
Total ICU  bedsc ICU beds per 
100,000 popu-
lation
High-income
 Australia 25,203,200 9618 25 January 2020 3.8 95,772 2200 8.7
 Belgium 11,539,326 11,899 04 February 
2020
6.2 71,544 1900 16.5
 Chile 18,952,035 2449 03 March 2020 2.2 41,694 1000 5.3
 The Nether-
lands
17,097,123 11,750 27 February 
2020
4.7 80,356 1150 6.7
Upper-middle income
 Colombia 50,339,443 702 06 March 2020 1.5 75,509 5600 11.1
 Mexico 127,575,528 993 28 February 
2020
1.5 191,363 3000 2.4
 South Africa 58,558,267 1326 05 March 2020 2.5 146,396 1500 2.6
 Sri Lanka 21,323,734 112 27 January 2020 3.6 76,765 519 2.4
Lower-middle income
 Bangladesh 163,046,173 49 08 March 2020 0.8 130,437 1174 0.7
 India 1,366,417,755 1251 30 January 2020 0.9 1,229,776 29,997 2.2
 Nigeria 200,963,603 111 27 February 
2020
0.5 100,482 128 0.1
 Pakistan 216,565,317 1865 26 February 
2020
0.6 129,939 3142 1.5
Low-income
 Afghanistan 38,041,757 166 24 February 
2020
0.5 19,021 100 0.3
 Burkina Faso 20,321,383 246 09 March 2020 0.4 8,129 50 0.2
 Tanzania 58,005,461 19 16 March 2020 0.7 40,604 38 0.1
 Uganda 44,269,587 33 20 March 2020 0.5 22,135 55 0.1
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cases requiring critical care (Table 2). IFR estimates were 
significantly higher in the HICs, compared to LMIC and 
LICs (range 0.17 in Burkina Faso to 1.13 in Belgium). 
Model development and predicted impact 
of the interventions
 Impact of uncontrolled or no intervention scenario In the 
unlikely scenario of no NPI, the number of cases requiring 
ICU care would exceed the available capacity significantly 
for every single country (Fig. 1). This unmitigated scenario, 
in aggregate, would also result in 7,840,444 deaths in all 
16 countries. This estimate would have been equivalent to 
approximately 46% of all deaths recorded in these countries 
in 2017. Additionally, an uncontrolled epidemic would pre-
dict 583,738 total deaths in the HIC, 1,026,361 deaths in the 
HMIC, 6,000,220 deaths in the LMIC, and 230,125 deaths in 
the LIC settings. The majority of these deaths will occur in 
India, proportionate to the large population of this country. 
Under this scenario, the duration of the epidemic will last 
nearly 200 days in the majority of the included countries 
(Fig. 1).
Comparing impacts of dynamic cycles of mitigation/
suppression and relaxation Our models predict that simul-
taneous cycles of 50-day mitigation intervention followed 
by a 30-day relaxation would likely to reduce the effective 
reproduction number R to 0.8 in all countries. However, 
this rolling mitigation measure was insufficient to keep the 
number of patients requiring healthcare below the avail-
able critical care capacity (Fig. 1). In this NPI scenario, 
the duration of pandemic appeared approximately 12 
months in the HIC, and was close to 18 months in the other 
settings. Additionally, dynamic mitigation interventions 
were effective at the first 3 months for all the countries, 
but after the first relaxation, the pandemic would exceed 
the hospital capacity in all the countries and would result 
in 3,534,793 deaths. By contrast, we found that dynamic 
cycles of 50-day suppression followed by a 30-day relaxa-
tion, aimed at reducing the effective R to 0.5, were suitable 
for all settings to keep ICU demand within national capac-
ity (Fig. 1). Since more individuals remain susceptible at 
Table 2  Age-standardised estimates for case severity and fatality of COVID-19 for 16 included countries
All estimates are standardised according to the age structure of the respective country
a Age-specific proportions of infected individuals hospitalised were taken from Verity et  al. [18]. These proportions were adjusted for under-
ascertainment and corrected for demography. We assumed that cases defined as severe would be hospitalised
b Age-specific proportions of hospitalised cases requiring critical care were taken from Imperial COVID-19 Response Team Report [4]
c Age-specific proportions of individuals requiring critical care die were calculated by dividing the IFRs with proportions of infected individuals 
hospitalised and proportions of hospitalised cases requiring critical care
d Age-specific IFRs were taken from Verity et al. [18]
Proportion of infected indi-
viduals  hospitaliseda (%)
Proportion of hospitalised cases 
requiring critical  careb (%)
Proportion of individuals requir-
ing critical care  diec (%)
Infection fatality 
ratio (IFR)d (%)
High-income
 Australia 5.34 29.3 59.6 0.93
 Belgium 6.01 31.5 59.6 1.13
 Chile 4.69 25.8 59.5 0.72
 The Netherlands 6.12 30.6 59.6 1.12
Upper-middle income
 Colombia 3.93 23.3 59.4 0.54
 Mexico 3.57 22.3 59.4 0.47
 South Africa 3.09 19.1 59.2 0.35
 Sri Lanka 4.38 24.2 59.5 0.63
Lower-middle income
 Bangladesh 3.10 19.6 59.3 0.36
 India 3.35 20.3 59.3 0.41
 Nigeria 1.96 16.3 59.1 0.19
 Pakistan 2.55 19.0 59.2 0.29
Low-income
 Afghanistan 1.86 16.4 59.1 0.18
 Burkina Faso 1.81 16.0 59.0 0.17
 Tanzania 1.90 16.3 59.0 0.18
 Uganda 1.61 15.1 58.9 0.15
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the end of each cycle of suppression and relaxation, such 
approach would result in a longer pandemic, beyond 18 
months in all countries; however, global mortality would 
drop to 131,643 during that period (Fig. 1).
Estimated impacts of dynamic mitigation and sup-
pression strategies on new infections, hospitalisations 
and deaths in all 16 countries have been summarised in 
Table 3. Briefly, the numbers of new infections per day 
(during the peak of epidemic) were significantly higher 
for all countries in no and dynamic mitigation intervention 
scenarios. Both new infections and ICU bed requirements 
per day (during the peak of epidemic) were significantly 
lower, especially for low-income settings, for dynamic 
suppression and relaxation strategy (Table 3). For dynamic 
mitigation strategies, mortality estimates were 266,835 
in HICs, 463,499 in HMICs, 2,700,162 in LMICs, were 
and 104,297 in LICs. The corresponding estimates for 
the dynamic suppression strategies were markedly lower: 
63,166 in HICs, 32,419 in HMICs, 32,210 in LMICs and 
3,848 in LICs (Table 3).
Sensitivity analyses As sensitivity analyses, we found 
that a single but continuous yearlong mitigation or sup-
pression strategy would be effective to keep the number 
of patients well below the available hospital capacity 
(Fig. 2). In case of suppression, in 3 months, most of 
the countries would not have any new cases to report. 
In case of sustained mitigation, countries would require 
approximately 6.5 months to reach a no-new-case sce-
nario (Fig.  2). Additionally, dynamic mitigation and 
suppression interventions implemented for a period of 
time less than 50 days led to an increase in the number 
of infections beyond the ICU healthcare capacities. The 
Fig. 1  Impact of dynamic interventions and relaxation on ICU beds requirement in 16 countries over an 18-month period
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same was observed for relaxation periods longer than 30 
days. 
Discussion
In this mathematical modelling study, we have assessed 
the potential impact of dynamic community-based NPIs, 
involving sixteen economically diverse countries, as a 
pragmatic strategy for controlling the COVID-19 pandemic 
in order to provide a practical illustration of interventions 
and strategies implemented to reduce the reproduction rate 
of COVID-19. Our study has several inter-related findings. 
First, we show that simultaneous cycles of 50-day mitiga-
tion (R value of 0.8) followed by a 30-day relaxation could 
provide means to reduce the effective reproduction number, 
however, will be insufficient to keep the number of patients 
requiring ICU care within manageable levels. Second, by 
contrast, we found that dynamic cycles of 50-day suppres-
sion (R value of 0.5) followed by a 30-day relaxation would 
be required, for all countries, to keep ICU demands below 
the national capacities. Third, significant number of new 
infections and deaths could be prevented if these “rolling” 
suppression measures can be maintained for an 18-month 
period, or until a suitable treatment and/or vaccination 
become available. Finally, a continuous, yearlong suppres-
sion strategy may also reduce overall attack rates signifi-
cantly and appears effective. However, implementation (and 
socioeconomic sustenance) of such stringent measure could 
be challenged by its detrimental impacts on population well-
being and livelihood.
Our findings may have several explanations. First, despite 
higher rates of contact across older age groups [3], we pre-
dict a somewhat lower incidence of ICU hospitalisation and 
deaths in low-income settings. This can be explained, at 
least partly, by the demographic differences with a relatively 
younger average age structure of these populations, and 
absence of integrated death registration system. However, 
given the significant inequalities in baseline health, test-
ing capabilities and critical care infrastructure across the 
Table 3  The estimated impacts of various interventions on COVID-19 outcomes in 16 countries
Countries 
and income 
categories
Uncontrolled, no intervention scenario Intermittent cycles of mitigation and 
relaxation
(Effective R = 0.8)
Intermittent cycles of suppression and 
relaxation
(Effective R = 0.5)
New infec-
tions/day 
during the 
peak
ICU bed 
needs/day 
during the 
peak
No. of total 
deaths over 
18 months
New infec-
tions/day 
during the 
peak
ICU bed 
needs/day 
during the 
peak
No. of total 
deaths over 
18 months
New infec-
tions/day 
during the 
peak
ICU bed 
needs/day 
during the 
peak
No. of total 
deaths over 
18 months
High-income
 Australia 1,434,638 59,803 197,746 418,643 14,798 89,091 54,748 1734 19,996
 Belgium 657,883 33,213 109,785 253,150 10,674 51,151 63,135 2404 15,846
 Chile 1,078,061 34,818 115,060 357,316 9716 53,210 18,351 450 7505
 The Neth-
erlands
973,779 48,724 161,147 354,373 14,831 73,383 63,412 2395 19,819
Upper-middle income
 Colombia 2,862,000 69,878 230,682 988,841 20,225 104,040 30,730 570 9239
 Mexico 7,253,642 154,507 509,794 2,082,308 37,598 228,879 53,308 863 12,047
 South 
Africa
3,329,773 52,421 172,416 1,189,739 15,674 79,091 44,377 531 9094
 Sri Lanka 1,212,623 34,335 113,469 282,813 6876 51,489 7875 170 2039
Lower-middle income
 Bangladesh 9,270,170 150,503 495,420 2,427,104 33,631 226,700 36,597 452 4908
 India 77,698,771 1,414,384 4,660,013 26,185,375 399,982 2,093,893 87,558 1211 15,379
 Nigeria 11,426,973 97,411 319,598 2,944,575 21,424 144,049 7894 51 659
 Pakistan 12,316,925 159,636 525,189 3,653,682 40,072 235,520 86,084 848 11,264
Low-income
 Afghani-
stan
2,163,088 17,640 57,851 550,669 3839 26,401 6989 43 614
 Burkina 
Faso
1,155,479 8918 29,228 388,909 2519 13,154 11,838 69 1080
 Tanzania 3,297,673 27,308 89,543 809,325 5740 40,755 16,653 105 905
 Uganda 2,516,788 16,350 53,503 804,079 4397 23,987 20,095 99 1249
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countries, in reality, a higher overall level of excess deaths 
are likely in resource-poor settings owing to health systems 
failure, especially in uncontrolled or mitigation intervention 
scenarios. Second, it was unsurprising that a more restric-
tive suppression strategy (R: 0.5) in our study reduced ICU 
hospitalisations and deaths for all countries. This is because 
a further reduction in the reproductive number secondary 
to more stringent interventions can maximally reduce the 
population transmissibility of the SARS-CoV-2 [24]. Nota-
bly, implementation of such strategies also creates a policy 
dilemma for many low-income countries: how to address the 
“competing priorities” of preventing COVID-19 associated 
deaths and public health system failure with the long-term 
economic collapse and hardship. In this regard, we have 
observed that in contrast to a long fixed-duration social 
distancing, dynamic NPIs (that reduce the overall attack 
rates effectively) may offer a helpful balance.
Third, in our study, dynamic cycles of 50-day suppres-
sion followed by a 30-day relaxation were effective to lower 
the deaths significantly for all countries since both trans-
missibility and case severity (and by extension, critical 
care demands) were significantly reduced throughout the 
18-month period. Notably, this intermittent combination 
of strict social distancing, and a relatively relaxed period 
(with efficient testing, case isolation, contact-tracing and 
shielding of the vulnerable), may allow populations and the 
national economies to “breathe” at intervals—a potential 
that might make this solution more sustainable, especially in 
resource-poor regions [25]. The specific durations of these 
interventions can be defined by specific countries according 
to their needs and local facilities, what is key is to identify a 
Fig. 2  Impact of single, sustained mitigation or suppression strategy on total deaths in 16 countries over a 12-month period
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combination pattern that allows to protect the health of the 
population not only from COVID-19 but also from economic 
hardship and mental health issues. Finally, these findings 
reinforce the value of dynamic social distancing strategies 
estimated by earlier studies for the UK, Canada and China 
[3, 25, 26], and extend these to multiple global regions under 
various dynamic intervention scenarios.
The strengths and limitations of our study merit care-
ful consideration. First, as restrictive NPIs may need to be 
maintained worldwide for many months, we have examined 
the impacts of dynamic NPIs to “switch on” and “switch 
off” at regular intervals. These measures have shown to be 
largely unaffected to uncertainties in effective R estimates 
and in the severity of the virus [4]. Second, NPI strategies 
only blunt (however prolong) the epidemic cycle, since there 
is lesser build-up of herd immunity while these interven-
tions are kept in place. If these measures are, however, lifted 
altogether, a second (potentially more serious) outbreak 
could occur [27]. Therefore, in the absence of individual-
level data and more detailed country-specific parameters, 
our study provides an illustrative comparison of different 
“rolling” strategies to suggest (a) when such measures could 
be lifted, and (b) for how long. Third, we used the most up-
to-date disease transmission parameters [4, 17, 18, 20] to 
construct our adaptive models, based on well-established 
SEIR model of epidemic dynamics for infectious diseases. 
Fourth, since different interventions are likely to be imple-
mented differentially and may have a heterogeneous effect 
in multiple locations, we have chosen a broad illustrative 
target of reducing the reproduction number R rather than 
specific community measures that may differ significantly 
by context. Fifth, we employed age-standardized estimates 
of hospitalization and infection-fatality-ratios in countries 
with diverse demographic structures, and considered coun-
tries at various categories of national income, in order to 
provide useful “context-specific” estimates. Finally, we used 
rise-and-fall timescale of infections (50 days, in the absence 
of intervention) as the ideal intervention duration and cal-
culated 30-day as the optimal break duration before trigger-
ing the next cycle, however specific to each country other 
combinations could be considered depending the specific 
settings and availability of resources. In this regard, trigger-
ing dynamic interventions based on a specific pre-specified 
mortality number or rate, as was done in earlier modelling 
for the UK [3], would not be optimal for under-developed 
countries since (a) the health systems are less efficient to 
ascertain all new cases comprehensively, and (b) a younger 
demographic would mean that by the time the target mortal-
ity threshold is reached for the trigger, the countries have 
already accrued a significantly large number of cases.
Our study also had several important limitations. In the 
absence of country-specific, real-time, reproduction numbers 
for the epidemic, we assumed a constant transmission rate 
during each modeled cycle. These estimates are likely to 
vary by a population’s adherence to the NPI and the mix of 
specific measures put in place. In this respect, our chosen 
effective R estimates of 0.8 and 0.5 reflect two scenarios 
of weaker and stronger reduction in transmission, respec-
tively, which could be achieved through social distanc-
ing measures and the interruption of transmission chains 
(e.g., through ramping up testing, contact tracing, isolation 
and quarantine and other potential strategies chosen by indi-
vidual countries). We anticipate that the countries will be 
able to introduce additional control measures with time that 
might counterbalance the detrimental effect of decreasing 
compliance. The age-standardisation analyses were based on 
public sector surveillance data, which may not be robust for 
all LMIC and LIC countries, with potentials for underesti-
mation of cases and deaths. Furthermore, given unavailabil-
ity of relevant data, we were unable to adjust for wider social 
and economic costs of the dynamic approaches; further stud-
ies will be needed to quantify these aspects. Additional fac-
tors such as potential seasonal variations, environmental pol-
lutions or structural determinants may influence, at least in 
part, these interventions, highlighting the need of flexibility 
in terms of the suitable strategy and combination of inter-
ventions that can be implemented in each country. Finally, 
similar to all modelling studies, our analyses were based 
on several transmission parameter assumptions. Since some 
uncertainties exist around the natural history and local trans-
mission dynamics of the SARS-CoV-2, the precise efficacy 
and optimal duration of the dynamic strategies may differ 
for other countries and will need to be tailored accordingly.
Our study may have important implications. First, we 
have reported several findings relevant to COVID-19 man-
agement and policy development. We provide an action-
able strategy option for COVID-19 control by employing 
dynamic interventions that could delay the epidemic peak, 
while allowing time to enhance health systems capacities 
and efforts to develop therapies or vaccines. These dynamic 
measures also allow interim periods of relaxation in order 
to minimise socioeconomic disruptions and maximise popu-
lation compliance to these stringent suppression measures. 
However, these should be weighed carefully against costs, 
any risks imposed to the society, and the social protection 
available in each setting. Second, these findings also stimu-
late further relevant research that may involve: (a) more in-
depth analyses of detailed natural history of the disease (e.g., 
including transmissibility in asymptomatic state) based on 
patient-level data, when available, from various countries 
[28], (b) various spatial pathways and patterns of epidemic 
in different circumstances (e.g., co-morbidity, reinfection) 
and settings (e.g., urban vs. rural); and (c) targeted mod-
elling studies accounting for genomic susceptibility [29], 
social behaviour [30] and economic diversity [3].
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In conclusion, this multi-country analysis demonstrates 
that intermittent reductions of R below 1 through a poten-
tial combination of suppression interventions and relaxa-
tion can be a pragmatic strategy for COVID-19 pandemic 
control. Such a “schedule” of social distancing might be 
particularly relevant to low-income countries, where a sin-
gle, prolonged suppression intervention is unsustainable. As 
a policy option, efficient implementation of dynamic sup-
pression interventions worldwide, therefore, would help: (1) 
prevent critical care overload and deaths, (2) gain time to 
develop preventive and clinical measures, and (3) reduce 
economic hardship globally.
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